NEW YORK, May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Bitfarms Ltd. (NASDAQ: BITF).Shareholders who purchased shares of BITF during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/bitfarms-ltd-loss-submission-form/?id=149540&from=4CLASS PERIOD: March 21, 2023 to December ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Rocket Companies, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical financial information during a specified class period [1][2]. Summary by Sections Class Period and Allegations - The class period is defined as March 29, 2021, to April 1, 2021 [2]. - Allegations include that Rocket's gain on sale margins were contracting at the highest rate in two years due to increased competition among mortgage lenders and a shift towards lower-margin operations [2]. - The company was reportedly engaged in a price war, further compressing margins in its Partner Network segment [2]. - It is claimed that adverse trends were accelerating, with gain on sale margins expected to drop by at least 140 basis points in the first half of 2021 [2]. - The favorable market conditions that previously allowed Rocket to achieve high gain on sale margins had disappeared, returning to levels not seen since Q1 2019 [2]. - Overall, the positive statements made by the defendants regarding the company's operations were deemed materially misleading [2]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 8, 2025, to participate in the case [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software [3]. - There is no cost or obligation for shareholders to participate in the case [3]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Ibotta, Inc. regarding a class action lawsuit due to alleged misleading statements related to a contract with Kroger, which could have significant implications for investors [1][2]. Group 1: Allegations and Legal Context - The lawsuit alleges that Ibotta failed to disclose the at-will nature of its contract with Kroger, which allowed Kroger to terminate the agreement without notice, posing a risk to investors [2]. - Ibotta provided detailed information about its contract with Walmart but did not adequately warn investors about the potential risks associated with the Kroger contract [2]. Group 2: Shareholder Actions and Deadlines - Shareholders who purchased Ibotta shares during the specified class period are encouraged to register for the class action, with a deadline set for June 16, 2025 [3]. - Once registered, shareholders will receive updates on the case through a portfolio monitoring software, and there is no cost to participate [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements or omissions by companies [4]. - The firm emphasizes its commitment to responsible business practices and good corporate citizenship [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Krispy Kreme, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from February 25, 2025, to May 7, 2025 [3]. - Allegations include: - A significant decline in demand for Krispy Kreme products at McDonald's locations following the initial marketing launch [3]. - This decline contributed to decreasing average sales per door per week [3]. - The partnership with McDonald's was reportedly not profitable [3]. - The aforementioned issues posed a substantial risk to the continuation of the partnership with McDonald's [3]. - As a result, the company would pause its expansion into new McDonald's locations [3]. - Positive statements made by the defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 15, 2025, to participate in the case [4]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [5].

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA). Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ibotta-loss-submission-form/?id=149360&from=3 CLASS PERIOD: This lawsuit is on behalf of ...

NEW YORK, May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Compass Group Diversified Holdings, LLC (NYSE: CODI).Shareholders who purchased shares of CODI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/compass-diversified-loss-submission-form/?id=148838&from=4 CLASS PER ...

Core Viewpoint - Zynex, Inc. is facing allegations of issuing materially false and misleading statements regarding its business practices, particularly related to inflated revenue and improper product shipments during the class period from March 13, 2023, to March 11, 2025 [1]. Group 1: Allegations Against Zynex, Inc. - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - As a result of these practices, Zynex is likely to face adverse consequences, including potential removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - Shareholders who purchased shares of ZYXI during the specified class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1][2]. - The deadline for shareholders to register for the class action and seek lead plaintiff status is May 19, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [2].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Treace Medical Concepts, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information affecting the company's stock value [1][3]. Group 1: Allegations and Impact - The complaint alleges that during the class period from May 8, 2023, to May 7, 2024, Treace Medical faced competition that negatively impacted the demand for its primary product, the 3D bunion correction system known as "Lapiplasty" [1]. - As a result of the competition, Treace Medical's revenue declined, prompting the company to accelerate plans for an alternative product to osteotomy [1]. - The defendants' positive statements regarding the company's business and prospects were claimed to be materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - Shareholders who purchased TMCI shares during the specified class period are encouraged to register for the class action, with a deadline set for June 10, 2025 [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - The lawsuit against Cerevel Therapeutics Holdings, Inc. alleges that the company and its controlling shareholder, Bain Capital, engaged in misleading practices regarding a secondary stock offering and the subsequent acquisition by AbbVie, resulting in significant financial losses for shareholders [2]. Group 1: Allegations and Financial Impact - Cerevel's October 16, 2023 secondary stock offering documents allegedly omitted material facts about AbbVie's interest in acquiring Cerevel at a price significantly higher than the offering price of $22.81 per share, which artificially deflated Cerevel's stock price until the merger announcement [2]. - Bain Capital acquired shares during the October Offering at a depressed price while allegedly possessing nonpublic information about AbbVie's acquisition interest, leading to a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [2]. - Cerevel's January 18, 2024 Proxy statement is claimed to have misled investors regarding the nature and timing of AbbVie's interest in the company [2]. Group 2: Class Action Details - The class period for the lawsuit includes shareholders who sold or disposed of Cerevel stock from October 11, 2023, to August 1, 2024, and those who held shares as of January 8, 2024, entitled to vote on the merger [1]. - The deadline for shareholders to register for the class action and seek lead plaintiff status is June 3, 2025, with no cost or obligation to participate [3].

NEW YORK, May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS).Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=148823&from=4CLASS PERIOD: August 8, 2024 to February ...